TREATMENT OUTCOME OF TUBERCULOSIS CASES AMONG PAEDIATRIC PATIENTS IN WESTERN RAJASTHAN
DOI:
https://doi.org/10.22159/ijcpr.2024v16i4.5021Keywords:
Drug resistant tuberculosis, Paediatric patients, Treatment outcome, Western RajasthanAbstract
Objective: This study aimed to identify drug-resistant tuberculosis cases and treatment results. Because it is one of the few studies that have looked at the results of TB treatment among children in the nation, this one was noteworthy.
Methods: Drug-resistant cases of paediatric TB were recruited from various districts of Western Rajasthan. Drug resistance in Mycobacterium tuberculosis was detected by line Probe Assay. The cases were followed up for treatment.
Results: A total of 41 drug-resistant TB cases were evaluated. Out of 41, 21 were rifampicin mono-resistant, 8 were isoniazid mono-resistant, MDR and pre-XDR were 5 each, and XDR cases were 2. 19 cases were successfully cured and there was one death reported during treatment.
Conclusion: Cure rate of paediatric TB is less than 50% in our region. Adherence to treatment and contact isolation are crucial to increase cure rate and decrease the incidence of drug-resistant TB.
Downloads
References
Global tuberculosis report; 2022. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022 [Last accessed on 26 Sep 2023]
Swaminathan S, Rekha B. Pediatric tuberculosis: global overview and challenges. Clin Infect Dis. 2010 May 15;50Suppl 3:S184-94. doi: 10.1086/651490, PMID 20397947.
Mirutse G, Fang M, Kahsay AB, Ma X. Epidemiology of childhood tuberculosis and factors associated with unsuccessful treatment outcomes in Tigray, Ethiopia: a ten-year retrospective cross sectional study. BMC Public Health. 2019 Oct 24;19(1):1367. doi: 10.1186/s12889-019-7732-y, PMID 31651319.
Vukugah TA, Akoku DA, Tchoupa MM, Lambert E. Epidemiology of pediatric tuberculosis and factors associated with unsuccessful treatment outcomes in the centre region of cameroon: a three-year retrospective cohort study. Interdiscip Perspect Infect Dis. 2022;2022:2236110. doi: 10.1155/2022/2236110, PMID 36061949.
Gopie FA, Commiesie E, Baldi S, Kamst M, Kaur D, de lange WC. Should the treatment of low-level rifampicin mono-resistant tuberculosis be different? J Clin Tuberc Other Mycobact Dis. 2021 Jan 29;23:100222. doi: 10.1016/j.jctube.2021.100222. PMID 33598570, PMCID PMC7869001.
Villegas L, Otero L, Sterling TR, Huaman MA, Van der Stuyft P, Gotuzzo E. Prevalence, risk factors, and treatment outcomes of isoniazid- and rifampicin-mono-resistant pulmonary tuberculosis in lima, Peru. PLOS ONE. 2016 Apr 5;11(4):e0152933. doi: 10.1371/journal.pone.0152933, PMID 27045684, PMCID PMC4821555.
Chien JY, Chen YT, Wu SG, Lee JJ, Wang JY, Yu CJ. Treatment outcome of patients with isoniazid mono-resistant tuberculosis. Clin Microbiol Infect. 2015;21(1):59-68. doi: 10.1016/j.cmi.2014.08.008, PMID 25636929.
Cornejo Garcia JG, Alarcon Guizado VA, Mendoza Ticona A, Alarcon E, Heldal E, Moore DA. Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014. PLOS ONE. 2018 Dec 4;13(12):e0206658. doi: 10.1371/journal.pone.0206658, PMID 30513085, PMCID PMC6279036.
Aaina M, Venkatesh K, Usharani B, Anbazhagi M, Rakesh G, Muthuraj M. Risk factors and treatment outcome analysis associated with second-line drug-resistant tuberculosis. JoR. 2022;2(1):1-12. doi: 10.3390/jor2010001.
El Hamdouni M, Bourkadi JE, Benamor J, Hassar M, Cherrah Y, Ahid S. Treatment outcomes of drug resistant tuberculosis patients in morocco: multi-centric prospective study. BMC Infect Dis. 2019 Dec;19(1):316. doi: 10.1186/s12879-019-3931-5, PMID 30975090.
Published
How to Cite
Issue
Section
Copyright (c) 2024 YOGESH YADAV, JYOTI CHOUDHARY, MOHAMMED NASIR KHAN
This work is licensed under a Creative Commons Attribution 4.0 International License.
